Loading clinical trials...
Loading clinical trials...
Multicenter Randomized Open-labelled Trial Which Aims to Show Non-inferiority of Adverse Events Risk During the Maintenance of Oral-anticoagulation in the Surgery of Benign Prostatic Hypertrophy by Laser Photovaporization
Conditions
Interventions
Maintenance of OAC in surgery of BPH by PVP.
Discontinuation of OAC in surgery of BPH by PVP.
Locations
1
France
Clinique Pasteur
Toulouse, France
Start Date
October 30, 2017
Primary Completion Date
November 30, 2027
Completion Date
May 31, 2028
Last Updated
March 6, 2026
NCT05574244
NCT07016620
NCT06312722
NCT06817733
NCT04757116
NCT06265519
Lead Sponsor
Clinique Pasteur
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions